Literature DB >> 24480502

Quantitative assessment of the subchondral vascularity of the talar dome: a cadaveric study.

Adam Lomax1, Roslyn J Miller2, Quentin A Fogg3, N Jane Madeley4, C Senthil Kumar4.   

Abstract

BACKGROUND: The arterial supply to the talus has been extensively studied previously but never to specifically examine the subchondral region of the talar dome, a frequent site of localised pathology. This study aims to analyse and quantify the subchondral vascularity of the talar dome.
METHODS: We performed cadaveric arterial injection studies. After processing, the vascularity to the subchondral region of the talar dome was visualised and mapped using three-dimensional computer technology, then quantified and reported using a nine-section anatomical grid.
RESULTS: The areas of relative poor perfusion across the talar dome are the posterior/medial, posterior/lateral and middle/medial sections of a nine-section grid. The rest of the subchondral region shows more richly vascularised bone.
CONCLUSIONS: The vascularity of the subchondral surface of the talar dome is not uniformly distributed. This may be relevant to the aetiology and management of osteochondral lesions and shows some correlation with their more frequent locations.
Copyright © 2013 European Foot and Ankle Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Blood supply; Intraosseous; Osteochondral lesions; Subchondral; Talus

Mesh:

Year:  2013        PMID: 24480502     DOI: 10.1016/j.fas.2013.10.005

Source DB:  PubMed          Journal:  Foot Ankle Surg        ISSN: 1268-7731            Impact factor:   2.705


  8 in total

Review 1.  Osteochondral lesions of the talar dome: an up-to-date approach to multimodality imaging and surgical techniques.

Authors:  Júlio Brandão Guimarães; Isabela Azevedo Nicodemos da Cruz; Caio Nery; Flávio Duarte Silva; Alípio Gomes Ormond Filho; Bruno Cerretti Carneiro; Marcelo Astolfi Caetano Nico
Journal:  Skeletal Radiol       Date:  2021-06-15       Impact factor: 2.199

Review 2.  Evaluation and Management of Osteochondral Lesions of the Talus.

Authors:  Christopher A Looze; Jason Capo; Michael K Ryan; John P Begly; Cary Chapman; David Swanson; Brian C Singh; Eric J Strauss
Journal:  Cartilage       Date:  2016-09-28       Impact factor: 4.634

3.  High-Density Autologous Chondrocyte Implantation as Treatment for Ankle Osteochondral Defects.

Authors:  Juan Manuel López-Alcorocho; Isabel Guillén-Vicente; Elena Rodríguez-Iñigo; Ramón Navarro; Rosa Caballero-Santos; Marta Guillén-Vicente; Mercedes Casqueiro; Tomás F Fernández-Jaén; Fernando Sanz; Santiago Arauz; Steve Abelow; Pedro Guillén-García
Journal:  Cartilage       Date:  2019-03-17       Impact factor: 4.634

Review 4.  Osteochondritis Dissecans: Current Understanding of Epidemiology, Etiology, Management, and Outcomes.

Authors:  Michael M Chau; Mikhail A Klimstra; Kelsey L Wise; Jutta M Ellermann; Ferenc Tóth; Cathy S Carlson; Bradley J Nelson; Marc A Tompkins
Journal:  J Bone Joint Surg Am       Date:  2021-06-16       Impact factor: 6.558

5.  Staging of Osteochondral Lesions of the Talus: MRI and Cone Beam CT.

Authors:  Magdalena Posadzy; Julie Desimpel; Filip Vanhoenacker
Journal:  J Belg Soc Radiol       Date:  2017-12-16       Impact factor: 1.894

6.  Validation of 9-Grid Scheme for Localizing Osteochondral Lesions of the Talus.

Authors:  Kevin D Martin; Trevor J McBride; Dylan P Horan; Amgad Haleem; Jeannie Huh; Adam Groth; Laura K Dawson
Journal:  Foot Ankle Orthop       Date:  2020-09-02

7.  Triplane osteotomy combined with talar non-weight-bearing area autologous osteochondral transplantation for osteochondral lesions of the talus.

Authors:  Yan Zhang; Jing-Qi Liang; Xiao-Dong Wen; Pei-Long Liu; Jun Lu; Hong-Mou Zhao
Journal:  BMC Musculoskelet Disord       Date:  2022-01-22       Impact factor: 2.362

8.  Anatomic risk factors for the occurrence of medial talar osteochondral lesions: a case-control study.

Authors:  Lena Sonnow; Tarek Omar Pacha; Maximilian Richter; Dilek Yapar; Mustafa Cetin; Omer Faruk Celik; Ozkan Kose
Journal:  Skeletal Radiol       Date:  2022-03-24       Impact factor: 2.128

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.